nhia logo

Quick Links
Search NHIA.org



Borfitz D. Living with the limits of managed care. 1999;5(6):37-42.

Borfitz D. Home infusion's future lies in distinguishing product from service. 1999;6(2):31-5.

Chielli JJ. Know thy self...and thy payer. 1997;3(10):37-9.

Deshotels D. By the hour: Time-based cost analysis. 1999;5(7):33-37.

Everard LJ. Pricing out profitability. 1999;5(4):28-32.

Franklin DM. Pricing methodologies for the infusion industry. 2001;7(2):41-2.

Hoffman P. Prospering under PPS. 1997;3(11):23-8.

Johnson K, Volkman G. Identifying and calculating activity-based pharmacy costs in home infusion and ambulatory care. 1998,4(6):15-21.

Khan ZM, Lawson KA. Providing home infusion therapies in Texas: A time study. 1996;2(4):30-43.

Lima H. Evaluating new drug delivery systems: Cost accounting methods. 1995;2(2):29-33.

NCPA. APHA, NACDS. Implementing effective change in meeting the demands of community pharmacy practice in the United States: A white paper. 1999;6(2):43-8.

McKeon T. Activity-based costing. 1995;1(12):27-30.

Richardson RJ. The infusion industry: Emerging business benchmarks. 1997;3(4):28-35.

Rodman BE and Counce J New research documents per diem cost of providing home infusion therapy. 2006.12(2):23-6.

Sullivan B. An average sales price (ASP) primer. 2006.12(2):18-21.

Virdee P. Contracting with managed care payers: Focus on profitable, collectible business. 1999;5(11):20-3.

Van Pool K. Update on ASP.INFUSION.2015;21(5):12-13.

Wen LK, Lawson KA, Khan ZM. A survey of operational costs incurred by home infusion pharmacies. 1997;3(8):44-51.